Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) is -9.18% lower on its value in year-to-date trading and has touched a low of $4.03 and a high of $9.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BCRX stock was last observed hovering at around $7.33 in the last trading session, with the day’s loss setting it -0.5%.
Currently trading at $6.83, the stock is -10.43% and -15.83% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.51 million and changing -6.82% at the moment leaves the stock -10.98% off its SMA200. BCRX registered 44.40% gain for a year compared to 6-month gain of -7.45%. The firm has a 50-day simple moving average (SMA 50) of $8.1144 and a 200-day simple moving average (SMA200) of $7.67265.
The stock witnessed a -13.10% loss in the last 1 month and extending the period to 3 months gives it a -12.77%, and is -13.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.15% over the week and 3.86% over the month.
Biocryst Pharmaceuticals Inc (BCRX) has around 580 employees, a market worth around $1.43B and $450.71M in sales. Fwd P/E is 30.83. Profit margin for the company is -19.72%. Distance from 52-week low is 69.48% and -28.11% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.93%).
with sales reaching $126.83M over the same period.The EPS is expected to grow by 82.47% this year, but quarterly earnings will post 24.65% year-over-year. Quarterly sales are estimated to grow 36.73% in year-over-year returns.
Biocryst Pharmaceuticals Inc (BCRX) Top Institutional Holders
342.0 institutions hold shares in Biocryst Pharmaceuticals Inc (BCRX), with institutional investors hold 82.34% of the company’s shares. The shares outstanding are 208.54M, and float is at 197.24M with Short Float at 10.03%. Institutions hold 81.18% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 19.96 million shares valued at $123.33 million. The investor’s holdings represent 9.6676% of the BCRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 18.77 million shares valued at $116.0 million to account for 9.1086 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 12.57 million shares representing 6.0894% and valued at over $77.68 million, while STATE STREET CORP holds 4.5279 of the shares totaling 9.35 million with a market value of $57.76 million.
Biocryst Pharmaceuticals Inc (BCRX) Insider Activity
The most recent transaction is an insider sale by Hutson Nancy J, the company’s Director. SEC filings show that Hutson Nancy J sold 7,000 shares of the company’s common stock on Dec 13 ’24 at a price of $7.54 per share for a total of $52780.0. Following the sale, the insider now owns 86638.0 shares.
Still, SEC filings show that on Jun 24 ’24, McKee Amy E (Director) disposed off 8,600 shares at an average price of $6.32 for $54352.0. The insider now directly holds 27,831 shares of Biocryst Pharmaceuticals Inc (BCRX).
